Starting Aug. 1, pharmaceutical and medical device companies must begin tracking and preparing to publicly report payments and other transfers of value made to physicians under the Physician Payments Sunshine Act. Doctors should ask industry representatives for an opportunity to review and, if necessary, correct all information that will be submitted to the government.